Kristie Gurley advises pharmaceutical, biotechnology, medical device, food, dietary supplement, and cosmetic clients on a variety of issues before FDA and other regulatory agencies. Ms. Gurley regularly assists with evaluating policy opportunities, preparing public comments, and drafting proposed legislation for FDA-regulated industries. She also provides advice on regulatory risk associated with acquisitions and mergers of biotechnology companies, in addition to conducting regulatory due diligence to support corporate transactions and securities filings.